Polygenic Risk Score Enhances Diagnosis and Prognostic Stratification in Idiopathic Pulmonary Fibrosis
Highlight
– A polygenic risk score (PRS) strongly associates with idiopathic pulmonary fibrosis (IPF) diagnosis across multiple large biobank cohorts.
– High-risk PRS predicts increased mortality or lung transplant risk in individuals diagnosed with IPF.
– The study leverages routinely collected electronic health records (EHR) and genetic data to evaluate PRS utility in real-world settings.
– Incorporation of PRS into clinical practice could enhance early identification and prognostication in IPF, pending further validation.
Study Background
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
